Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Surveal Pharmaceuticals is a Belgian pharmaceutical company that specializes in the development and commercialization of high-quality nutraceuticals and pharmaceutical products. The company focuses on several key therapeutic areas, including gynecology, urology, orthopedics, and general health, with a particular emphasis on fertility and prenatal care. Their product portfolio includes well-known brands such as Fertisur, Gynositol, and Vinalac, which are designed to address specific nutritional deficiencies and support physiological functions. Surveal operates with a strong international presence, exporting its products to numerous countries across Europe, Africa, and the Middle East. The company emphasizes rigorous quality standards and scientific research to ensure the efficacy and safety of its formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Surveal Pharmaceuticals.